Market Cap 2.30B
Revenue (ttm) 874.84M
Net Income (ttm) 263.86M
EPS (ttm) N/A
PE Ratio 6.89
Forward PE 33.93
Profit Margin 30.16%
Debt to Equity Ratio -4.02
Volume 13,148,700
Avg Vol 5,410,310
Day's Range N/A - N/A
Shares Out 250.80M
Stochastic %K 71%
Beta 0.74
Analysts Strong Sell
Price Target $20.18

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat HAE. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
Del_Gue
Del_Gue Mar. 21 at 11:55 PM
$BCRX I need the $30 BO on Monday just to get back all the money I’ve lost betting college basketball this weekend.
0 · Reply
Dpst2022
Dpst2022 Mar. 21 at 8:15 PM
$BCRX The amount of pumpers showing up here in drover.... Saying BCRX will hit 30 dollars This ain't seeing 30 dollars. I'll bet anyone here.
2 · Reply
Merlintrader
Merlintrader Mar. 21 at 7:53 PM
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Mar. 21 at 4:53 PM
$SNDX is the best performing comm'l-stage bio stock (in both oncology & non-oncology) as measured by its 3/20/26 close v. its 3.5 month high (since 12/1/25). The attachment lists all 92 commercial-stage oncology (MCs over $300MM) & non-oncology (MCs over $900MM) bio stocks 3/20/26 closing share price v. their 3.5 month high (again since 12/1/25). The table excludes DAWN & DVAX (both recently acquired). The $XBI is more or less unchanged over this time (up 0.5%) Note more than half of SNDX peers are off their recent highs by over 25%. $BCRX comes a close second to SNDX. BCRX's strong share price is likely due to the Betaville Uncooked alert this last week suggesting BCRX is in active M&A negotiations. $KNSA ranks third on the list $OCUL 's share price appears to provide a textbook example of why the odds are shareholder value is maximized via M&A exit in this peer group. As always, do not rely on the attachment. Verify the data points for yourself. This is not investment advice.
1 · Reply
RDeneronow
RDeneronow Mar. 21 at 3:08 PM
$BCRX A very comprehensive breakdown of BCRX , Definitely worth reading https://www.merlintrader.com/biocryst-after-transition/
1 · Reply
trustbutverify
trustbutverify Mar. 21 at 2:11 PM
$BCRX "Seriously considering the 4/17/26 $10 calls at $0.70 each. I can't think of a better entry point in this stock's history-$10 feels very achievable with this kind of volume."
1 · Reply
GriZlyBeAr
GriZlyBeAr Mar. 21 at 1:39 PM
$BCRX @TrustButVerifi this is the next buyout
0 · Reply
GriZlyBeAr
GriZlyBeAr Mar. 21 at 1:16 PM
$BCRX I also think it is strange the rumor and daily gains weren’t posted as a news story on think or swim.
0 · Reply
tkr
tkr Mar. 21 at 1:03 PM
$BCRX if the big buyers are in at $9.70 it is a steal for the little guys at $10. They would not get in this stock if they believed it would not go up from here.Look for $12 to start the week off and by Friday the price, if Trump doesn’t do some screwy thing, will be $15 and if the war ends $20 and higher. The only thing holding this down will be bad management and a Trump Garfunkel . Keep the movement going up and by July 4th we will be near $30..I got in on Thursday after doing major research. I do believe we see a lot of offers from big pharma companies but if played right with all the new things in the pipeline it would be crazy to let a company come in at $20 whereas in a month that price will be a joke of a offer and $30,$40 will be the competitive offer. Look for rumors of a buyout about to happen but like good execs do they negotiate with no news offered until a major deal is signed. I have been with AZpLD since it was at $3 and now into this. I do see me making a million soon
2 · Reply
GriZlyBeAr
GriZlyBeAr Mar. 21 at 12:55 PM
$BCRX very similar to DAWN, held its rumor gains and then more, options activity very low on the rumor just like the were with DAWN. Which is actually strange. But they might rush to get this deal done very quickly so it doesn’t give people time to load up more and or buy a bunch of options.
0 · Reply
Latest News on BCRX
BioCryst to Present at Upcoming Investor Conference

Feb 17, 2026, 7:00 AM EST - 4 weeks ago

BioCryst to Present at Upcoming Investor Conference


BioCryst Pharmaceuticals, Inc. (BCRX) M&A Call Transcript

Oct 14, 2025, 1:16 PM EDT - 5 months ago

BioCryst Pharmaceuticals, Inc. (BCRX) M&A Call Transcript


BioCryst to buy Astria Therapeutics in $700 million deal

Oct 14, 2025, 7:35 AM EDT - 5 months ago

BioCryst to buy Astria Therapeutics in $700 million deal

ATXS


BioCryst: Blue Light Special In Small Cap Biotech Aisle

Sep 29, 2025, 2:53 AM EDT - 6 months ago

BioCryst: Blue Light Special In Small Cap Biotech Aisle


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 7 months ago

BioCryst Announces Departure of Dr. Helen Thackray


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 10 months ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst to Present at Upcoming Investor Conferences

May 27, 2025, 7:00 AM EDT - 10 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst: Strong Opportunity For A Double With A Proven Therapy

May 5, 2025, 2:05 PM EDT - 11 months ago

BioCryst: Strong Opportunity For A Double With A Proven Therapy


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 11 months ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst to Report First Quarter 2025 Financial Results on May 5

Apr 21, 2025, 7:00 AM EDT - 11 months ago

BioCryst to Report First Quarter 2025 Financial Results on May 5


Del_Gue
Del_Gue Mar. 21 at 11:55 PM
$BCRX I need the $30 BO on Monday just to get back all the money I’ve lost betting college basketball this weekend.
0 · Reply
Dpst2022
Dpst2022 Mar. 21 at 8:15 PM
$BCRX The amount of pumpers showing up here in drover.... Saying BCRX will hit 30 dollars This ain't seeing 30 dollars. I'll bet anyone here.
2 · Reply
Merlintrader
Merlintrader Mar. 21 at 7:53 PM
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Mar. 21 at 4:53 PM
$SNDX is the best performing comm'l-stage bio stock (in both oncology & non-oncology) as measured by its 3/20/26 close v. its 3.5 month high (since 12/1/25). The attachment lists all 92 commercial-stage oncology (MCs over $300MM) & non-oncology (MCs over $900MM) bio stocks 3/20/26 closing share price v. their 3.5 month high (again since 12/1/25). The table excludes DAWN & DVAX (both recently acquired). The $XBI is more or less unchanged over this time (up 0.5%) Note more than half of SNDX peers are off their recent highs by over 25%. $BCRX comes a close second to SNDX. BCRX's strong share price is likely due to the Betaville Uncooked alert this last week suggesting BCRX is in active M&A negotiations. $KNSA ranks third on the list $OCUL 's share price appears to provide a textbook example of why the odds are shareholder value is maximized via M&A exit in this peer group. As always, do not rely on the attachment. Verify the data points for yourself. This is not investment advice.
1 · Reply
RDeneronow
RDeneronow Mar. 21 at 3:08 PM
$BCRX A very comprehensive breakdown of BCRX , Definitely worth reading https://www.merlintrader.com/biocryst-after-transition/
1 · Reply
trustbutverify
trustbutverify Mar. 21 at 2:11 PM
$BCRX "Seriously considering the 4/17/26 $10 calls at $0.70 each. I can't think of a better entry point in this stock's history-$10 feels very achievable with this kind of volume."
1 · Reply
GriZlyBeAr
GriZlyBeAr Mar. 21 at 1:39 PM
$BCRX @TrustButVerifi this is the next buyout
0 · Reply
GriZlyBeAr
GriZlyBeAr Mar. 21 at 1:16 PM
$BCRX I also think it is strange the rumor and daily gains weren’t posted as a news story on think or swim.
0 · Reply
tkr
tkr Mar. 21 at 1:03 PM
$BCRX if the big buyers are in at $9.70 it is a steal for the little guys at $10. They would not get in this stock if they believed it would not go up from here.Look for $12 to start the week off and by Friday the price, if Trump doesn’t do some screwy thing, will be $15 and if the war ends $20 and higher. The only thing holding this down will be bad management and a Trump Garfunkel . Keep the movement going up and by July 4th we will be near $30..I got in on Thursday after doing major research. I do believe we see a lot of offers from big pharma companies but if played right with all the new things in the pipeline it would be crazy to let a company come in at $20 whereas in a month that price will be a joke of a offer and $30,$40 will be the competitive offer. Look for rumors of a buyout about to happen but like good execs do they negotiate with no news offered until a major deal is signed. I have been with AZpLD since it was at $3 and now into this. I do see me making a million soon
2 · Reply
GriZlyBeAr
GriZlyBeAr Mar. 21 at 12:55 PM
$BCRX very similar to DAWN, held its rumor gains and then more, options activity very low on the rumor just like the were with DAWN. Which is actually strange. But they might rush to get this deal done very quickly so it doesn’t give people time to load up more and or buy a bunch of options.
0 · Reply
Ttubular
Ttubular Mar. 21 at 12:11 PM
$BCRX I would love to be halted PM pending news on Monday but don’t think that’s really going to happen. If not what would be nice is at least a PR confirming that there was an offer but a low one. At least we would know there’s interest and maybe that would bring in other interested parties and they start bidding for BCRX. So I would absolutely love if one of those situations happened on Monday. Long n strong 💪
1 · Reply
SmallCupBullSwing
SmallCupBullSwing Mar. 21 at 8:32 AM
$BCRX https://x.com/i/status/2035071283117895973 Eventually we will be aquired.
0 · Reply
JacksRHi
JacksRHi Mar. 21 at 7:51 AM
$BCRX Nice close. About time.
1 · Reply
Smnorgy1
Smnorgy1 Mar. 21 at 3:04 AM
$BCRX. 7 billion....28 bucks a share, or nothing???
2 · Reply
simple1
simple1 Mar. 21 at 2:31 AM
$BCRX is a bio that has clearly made it. They're surviving. BCRX may not be huge winner many of the kings here hoped for, but most of its peers from where this started are long gone, and not from buyouts, lol. At least shareholders here are still solvent. This hasn't been BO yet, so I don't think it ever will. At least not without its story changing significantly.
1 · Reply
DragonAlgo
DragonAlgo Mar. 21 at 1:25 AM
🐉 $BCRX CALL — DragonAlgo® Signal Contract: BCRX CALL Expiry: 2027-01-15 | Strike: $10.00 | Type: CALL Option Plan (premium): Entry: $2.00 Stop: $1.44 TP1: $2.60 TP2: $3.40 TP3: $4.80 🔗 https://dragonalgo.com
0 · Reply
Ttubular
Ttubular Mar. 21 at 12:01 AM
0 · Reply
Ttubular
Ttubular Mar. 21 at 12:01 AM
$BCRX some nice buying in AH. Monday is a big day the way they took us down hard and then we recovered in AH. Let’s c what happens Monday. Best case scenario we get halted for pending news PM and then boom BO pr. $20
1 · Reply
1point21gigawatts
1point21gigawatts Mar. 20 at 11:12 PM
$BCRX any “longs” taking profits?
raylin
raylin Mar. 20 at 10:18 PM
1 · Reply
Vanderm98
Vanderm98 Mar. 20 at 10:14 PM
$BCRX Great week. No clue if rumors are correct, but they sure caused a nice reaction and it held up really well today. GL
1 · Reply
raylin
raylin Mar. 20 at 10:05 PM
$BCRX Criminal thugs kill the optics and we go right back above $10 AH on a Friday. Not back to the HOD, but still interesting.
0 · Reply